Adhesion GPCRs are a large class of surface proteins that recognize chemical and mechanical stimuli in the body. The rapidly expanding body of knowledge on the therapeutic targeting of these receptors ...

The idea that eggs are a “hot” food best avoided during summer has persisted for generations, yet a widely shared reel now calls it a myth, so what does the evidence actually say?

(“PMV Pharma” or the “Company”; Nasdaq: PMVP), a precision oncology company pioneering the discovery and development of small molecule therapies targeting p53, today announced that results from the ...

Linnaeus Therapeutics, Inc., a privately held company focused on the development and commercialization of small molecule therapeutics for diseases of aging, today announced it has been awarded a ...

Acquisition includes HS235, a potentially best-in-class activin signalling inhibitor in clinical development for treatment of cardiopulmonary diseasesHS235 offers potential to treat pulmonary ...

The latest medical science reveals that healthy weight loss doesn't require special genes, diets, or exercise programs. The secret is controlling hunger.

If you're looking for ways to mitigate your risk of developing cardiovascular disease or experiencing a cardiac event, such as a heart attack or stroke, glucagon-like peptide-1 (GLP-1) ...

Most of these foods were never about preference—they were about making it to Friday, and the families who relied on them ...

Physician-scientist and acclaimed adipose tissue biologist to advise on first-in-class, oral MS 001 for obesity.

Pramorelin, also known in scientific literature as a synthetic ghrelin receptor agonist, has emerged as a notable peptide within the broader landscape of endocrine and metabolic research. Its primary ...

First clinical development program in sporadic ALS patients to show potential to restore STATHMIN-2 expression, a statistically significant effect on a neurofilament biomarker, and an overall trend of ...

GSK acquires 35Pharma for $950M. The primary focus is HS235, a selective PH drug reducing bleeding risk with metabolic ...